作者
June Y. Hou,Jocelyn Chapman,Ekaterina Kalashnikova,William E. Pierson,Karen Smith‐McCune,Geovanni Pineda,Reena M. Vattakalam,Alexandra Ross,Meredith Mills,Carlos J. Suarez,Tracy C. Davis,Robert P. Edwards,M.M. Boisen,Sarah Sawyer,Hsin-Ta Wu,Scott Dashner,Vasily N. Aushev,Giby V. George,Meenakshi Malhotra,Bernhard Zimmermann,Himanshu Sethi,Adam C. ElNaggar,Alexey Aleshin,James M. Ford
摘要
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. We examined the utility of circulating tumor DNA (ctDNA) as a prognostic biomarker for EOC by assessing its relationship with patient outcome and CA-125, pre-surgically and during post-treatment surveillance.